Welcome Message

Dear Ivana,

The Abstract Submission deadline for our TSANZSRS2020 ASM is next week! We look forward to receiving and reading all of the submitted research and hope to see you in Melbourne next year.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Lastly, please consider supporting the work of TSANZ members by contributing to the surveys at the end of this newsletter.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards - closing 11 October 2019

TSANZ Indigenous Respiratory Nursing Award - closes 30th October 2019

TSANZ Peter Phelan Research Award - closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health - closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / Brian Eaton PhD IPF Scholarship 2019 - EXTENDED closing date 30 October 2019



How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Lung Foundation Latest Awards and Grant Opportunities

$200,000 in Research Funding Open for Application

We’re pleased to offer over $200,000 in funding to support cutting-edge research initiatives across disease areas including lung cancer and Idiopathic Pulmonary Fibrosis. These research awards support projects focused on prevention, early diagnosis, treatment, psychological management or cure for a lung disease.

Current awards include:

  • Deep Manchanda Early Career Fellowship in Lung Cancer
  • Brian Eaton Memorial PhD Scholarship in Idiopathic Pulmonary Fibrosis Research
  • Cochrane Airways Australia Scholarship 2020

International Travel Grants

Are you looking to attend an international conference? You can apply for an A Menarini Australia Travel Grant, up to $3,000, for a number of upcoming events.

For more information, including application closing dates, click here.

Congratulations to Award-winning Researchers

Experts shared ground-breaking research at the 4th Biennial Australian Rare Lung Disease Short Course last month. The course was a sell-out, with delegates gaining access to the most up-to-date advances in the treatment and management of rare lung disease.

Congratulations to the award-winning researchers, including:

  • Best Scientific Abstract Presentation Award - A/Prof Cecelia Prele
  • ACTELION travel grant award for the best PAH abstract presentation - Dr James Anderson and Miss Suzanne Maiolo
  • Best Clinical Abstract Presentation Award - Dr Jun Khoo
  • CREATE prize for the best clinical or scientific abstract from a member of the CREATE training program - Dr Alan Teoh
  • PACT Grant-in-Aid Award - Dr Lauren Troy

For more information about our Research Award Program, click here.


We’re proud to present the biennial Australian Lung Cancer Conference (ALCC) for 2020. The theme, A Time of Hope in Lung Cancer, highlights the shifting landscape in the lung cancer space and the challenging road ahead.

For the first time, the ALCC will join forces with the Australasian Lung Cancer Trials Group Annual Scientific Meeting (ALTG-ASM) and the Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF) to deliver a comprehensive three-day program that will engage and unite the lung cancer community like never before.

For more information, including details on abstract submissions, click here.

In order to register Click Here.

Submissions to PBAC for Treatment Reimbursement

At the November 2019 Pharmaceutical Benefits Advisory Committee (PBAC) meeting four lung cancer treatments will be considered for reimbursement through the Pharmaceutical Benefit Scheme.

In addition, two treatments for asthma and Chronic Obstructive Pulmonary Disease will be considered.

As part of the PBAC process, health professionals, patients, carers and community members are invited to make submissions in relation to the listing to help decision-makers understand the impact that a lung disease has and assist the PBAC in their considerations.

Submission for the November meeting close on Wednesday 9 October.

To read more, Click Here.

Bronchiectasis Registry Recruitment

Lung Foundation Australia has joined forces with clinicians, patients and researchers in New Zealand to support and develop a national registry to correspond with patient data collected via the Australian Bronchiectasis Registry. We are pleased to announce that recruitment to the New Zealand Bronchiectasis Registry has commenced. This is the first step in utilising international collaborations to improve clinical care across an Australasian footprint.

Research Shifts Focus on Lung Cancer

#InTheNews: Researchers from Walter and Eliza Hall Institute have discovered that the key to personalised therapies for some types of lung cancers may be to focus on their differences, not their similarities.

To read more about this exciting discovery, click here.

Respirology - Editor's Choice

Respirology Issue 24.10 October 2019

Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing

Andrew Burgess, Ken Goon, John D. Brannan, John Attia​​​​​​​, Kerrin Palazzi, Christopher Oldmeadow​​​​,​Tamera J. Corte​​​​​​​​​​​​​​, Ian Glaspole​​​​​​​​​​​​​​, Nicole Goh, Gregory Keir​​​​​​​​​​​​​​, Heather Allan, Sally Chapman, Wendy Cooper, Samantha Ellis, Peter Hopkins, Yuben Moodley​​​​​​​​​​​​​​, Paul Reynolds, Chris Zappala, Sacha Macansh​​​​​​​, Christopher Grainge

DOI: 10.1111/resp.13540


Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease

Lauren K. Troy, Iven H. Young, Edmund M.T. Lau, Keith K.H. Wong, Brendon J. Yee, Paul J. Torzillo, Tamera J. Corte

Example of a hypnogram in a patient with interstitial lung disease

DOI: 10.1111/resp.13549

Research Project and Survey Requests


Dear TSANZ Members,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice in regards to Advance Care Planning in patients with chronic obstructive pulmonary disease (COPD). 

This study is being conducted by:
Ms Mary Roberts, Dr Tracy Smith, Professor Wheatley and Dr Jin-Gun Cho. Details and affiliations of the research team can be obtained by contacting Ms Mary Roberts by phone 0408 490 371 or email mary.roberts@health.nsw.gov.au

The results of the survey will form part of a research project with the aim to develop resources to improve the quality and uptake of advanced care planning in patients with COPD. This survey has been approved by the WSLHD HREC under authorisation number 5990 2019/ETH00197.

The estimated time to complete the survey is 10-15 minutes. If you exit out the survey early or don't click DONE on the final page, your responses will not be saved. You may skip questions if you wish, though we would prefer you didn’t.  

Your participation is voluntary and anonymous. Your contribution is greatly appreciated.
We thank you in advance for your participation.
Here is the link: https://www.surveymonkey.com/r/8S6TLF6


Ms MM Roberts

Mary Roberts
Clinical Nurse Consultant | Respiratory Ambulatory Care
Clinical Lecturer, Sydney Medical School, University of Sydney

Determining a Patient-Centred Model of Care in Severe Asthma: What can we learn from the views, needs, and challenges of Clinicians’ and Carers of people with Severe Asthma and COPD?

Phase 1- Clinicians’ group

Investigators: Dr Vanessa Clark, Professor Vanessa McDonald, Professor Peter Gibson, and Eleanor Majellano


You are invited to participate in a research study that explores the barriers and facilitators to the optimal management of severe asthma. This research is being conducted as part of the requirements for a PhD at the University of Newcastle by Eleanor Majellano, under the supervision of Professor Vanessa McDonald and Dr Vanessa Clark. We are investigating the barriers, facilitators and attitudes of clinicians and allied healthcare professionals towards the optimal management of severe asthma in various healthcare settings.

Before you decide whether or not you wish to participate in this study, it is important for you to understand why the research is being conducted and what it will involve.

Please download the information and participation forms here if you are interested or would like to contact the investigators:

Participation Information Sheet.

This study has been approved by the Hunter New England Human Research Ethics Committee Reference. If you have concerns or complaints about the conduct of this study you should contact:

Dr. Nicole Gerrand
Research Ethics & Governance Office
Hunter New England Local Health District
Email: HNELHD-HREC@health.nsw.gov.au

The manager is the person nominated to receive complaints from research participants.

You will need to quote reference number 2019/ETH00143.

Thank you for taking the time to consider this study.
If you wish to take part in it, please sign the attached consent form.
This information sheet is for you to keep.

Share Your Feedback on COPD-X

How do you use COPD-X in your health care setting? Tell us about your experience via a five-minute survey. Your responses will help us improve the usability of COPD-X for health professionals across Australia.

By submitting a completed survey, you will also go in the draw to win one of 20 AirSmart Spirometers (conditions apply).

To complete the survey, click here.

Kind Regards,

Juliet Brown
COPD Projects and Guidelines Manager


Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.